Despite Q's long silence, QAnon beliefs have never been more prevalent—and as Donald Trump prepares to reenter the White House, excitement among the faithful is at an all-time high.
The first medical treatment to use Crispr gene editing has been on the market for a year. Its complexity means few patients in the US have received it yet.
In Russia’s war against Ukraine, electronic warfare, including signal-jamming, anti-drone weapons, and innovative protections for critical military systems, has become a key piece of the conflict.
A software update was supposed to free up the PS Portal from its reliance on the PS5 and add a world of streamable games to its appeal. In practice, it does nothing of the sort.
With big cash prizes at stake—and AI supercharging research—interspecies translation is closer than ever. But what, if anything, would animals want to tell us?
Plagued by delays, tied to a rival’s electric platform, yet somehow still being clever and innovative, Ford’s European EV experiment embodies the automaker’s failure to commit to electric cars.
Google dominated the last era of search. Now the company and the US Justice Department are battling over how to set a fair playing field for generative AI.
